about
Spontaneous reperfusion after in situ thromboembolic stroke in miceIn vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophagesCerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke.Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI.Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.Exercise Does Not Protect against Peripheral and Central Effects of a High Cholesterol Diet Given Ad libitum in Old ApoE-/- Mice.In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure.Monitoring therapeutic effects in experimental stroke by serial USPIO-enhanced MRI.Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.MRI assessment of the intra-carotid route for macrophage delivery after transient cerebral ischemia.Cyclosporine in acute ischemic stroke.11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation.Magnetic resonance imaging biomarkers of exercise-induced improvement of oxidative stress and inflammation in the brain of old high-fat-fed ApoE-/- mice.Binding of the PET radiotracer [¹⁸F]BF227 does not reflect the presence of alpha-synuclein aggregates in transgenic mice.Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide.Does acute behavioral testing reflect successful ischemia in rats with transient middle cerebral artery occlusion?Spatiotemporal characterization of brain infarction by sequential multimodal MR imaging following transient focal ischemia in a Rat model of intra-arterial middle cerebral artery occlusion.Differential effects of amyloid-beta 1-40 and 1-42 fibrils on 5-HT1A serotonin receptors in rat brain.In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa).In vivo imaging of brain lesions with [(11)C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors.Pre- and post-treatment with cyclosporine A in a rat model of transient focal cerebral ischaemia with multimodal MRI screening.Amyloid-Beta Radiotracer [18F]BF-227 Does Not Bind to Cytoplasmic Glial Inclusions of Postmortem Multiple System Atrophy Brain Tissue.Synchrotron Radiation X-Ray Phase Micro-computed Tomography as a New Method to Detect Iron Oxide Nanoparticles in the BrainQuantification of Iron-Labeled Cells with Positive Contrast in Mouse BrainsBrain-Targeting Form of Docosahexaenoic Acid for Experimental Stroke Treatment: MRI Evaluation and Anti-Oxidant ImpactQuantitative effects of cell internalization of two types of ultrasmall superparamagnetic iron oxide nanoparticles at 4.7 T and 7 TMagnetic Resonance Elastography of Rodent BrainClinical Imaging of Choroid Plexus in Health and in Brain Disorders: A Mini-Review[Aptamers: selection and scope of applications]Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of strokeIn Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET ImagingThe apparent mechanical effect of isolated amyloid-β and α-synuclein aggregates revealed by multi-frequency MREEvaluation of Myelin Radiotracers in the Lysolecithin Rat Model of Focal Demyelination: Beware of Pitfalls!MRI coupled with clinically-applicable iron oxide nanoparticles reveals choroid plexus involvement in a murine model of neuroinflammation
P50
Q34483016-1F256F7F-EF2A-4575-BA99-7AED4DBA0E1EQ34794677-EE4B2B4D-3F95-482D-A1B3-43AA9EC5051FQ35498942-928C194B-EA9C-4B7B-96FA-60E4752E7E24Q36088159-EF3FFE64-3C30-4077-B9E8-359C6E23EFABQ37283568-3F18D929-E9FD-4109-850F-7CC641B6FBF7Q37314780-0A45823B-7654-4E1F-B6FA-2CA5ECA2882BQ39229352-79448212-ED7F-449E-BB33-3B271ECAE365Q45896495-98BB59E7-7C3E-4F80-8805-D3E2E720E907Q46119208-3E042256-1E10-4227-848D-45FC23B2BB39Q48152415-FF7C165D-F952-4EB0-97CF-EB766EB281B6Q48190147-FDB85590-B5AF-4146-B870-8F02531D659DQ48221518-70E8DD3C-3C17-4C9A-BB2E-ECC8AC1E1BA6Q48349072-B25400A5-2B89-46FF-BB62-32297FB8B362Q48459760-787CE982-59D0-4A41-8D5D-57EFD3E64584Q48748992-A36FE25B-7D37-458A-A08A-38A8543B4EA3Q48793530-A7A8CAF7-0C08-4001-8148-A70DDED2E33BQ48828451-A34E5AFF-B3B7-42DE-BA9F-EC62557FEEE3Q48834110-A9E08BCE-33DE-4252-9D37-1E8C355428ADQ53267275-3E8D9F0B-94A2-4DF0-AFA5-1CF8BF65482AQ53469733-8227E0BA-6A6C-492F-8435-254FF4A88A0FQ54429660-51FC194D-E226-4BBE-940B-9745CD5AC353Q55119582-FF5985A8-E9FF-4CCF-B770-54C6EB9CA458Q58142258-20D5646B-CBD3-407E-B0F9-66ED24DE6702Q58142311-D0AEB0D8-2264-4493-9719-9DD77D50979EQ58142323-26FB57F8-CCE7-4463-AADF-89C0D0E4F33CQ58142340-2A403F7B-91B3-49D1-8EB0-FE237B1FAE60Q59807195-69370633-9513-4EDE-83EC-98C4D5F65A86Q64252972-60E19CE2-E0F6-4E0D-8D9A-1FB949F05D0BQ83295729-E416CDF9-B8E2-448D-8390-02547D5355D2Q85989400-3FEE3C00-7BC0-4AE5-AD61-12DF7A6ECAF5Q89496195-DEAD738A-2134-4EEF-8388-E80679A70BCFQ91159146-97F084FA-9631-4EFE-80FF-330BF24BD9BBQ91687371-53432738-9065-43D7-89CA-7E6A5427F23AQ91809899-C6BEFBD9-8A2B-4106-A28F-97EC786D1CC1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabien Chauveau
@ast
Fabien Chauveau
@en
Fabien Chauveau
@es
Fabien Chauveau
@nl
Fabien Chauveau
@sl
type
label
Fabien Chauveau
@ast
Fabien Chauveau
@en
Fabien Chauveau
@es
Fabien Chauveau
@nl
Fabien Chauveau
@sl
prefLabel
Fabien Chauveau
@ast
Fabien Chauveau
@en
Fabien Chauveau
@es
Fabien Chauveau
@nl
Fabien Chauveau
@sl
P1053
I-9722-2014
P106
P21
P31
P3829
P496
0000-0002-4177-741X